These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24066798)

  • 1. Modeling study of phenylsulfonylfuroxan derivatives as P-gp inhibitors: a combined approach of CoMFA, CoMSIA and HQSAR.
    Gadhe CG; Balupuri A; Balasubramanian PK; Cho SJ
    Anticancer Agents Med Chem; 2014; 14(7):1019-30. PubMed ID: 24066798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series.
    Gadhe CG; Madhavan T; Kothandan G; Cho SJ
    BMC Struct Biol; 2011 Jan; 11():5. PubMed ID: 21269449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
    Jiang YR; Yang YY; Chen YL; Liang ZJ
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction field based and hologram based QSAR analysis of propafenone-type modulators of multidrug resistance.
    Kaiser D; Smiesko M; Kopp S; Chiba P; Ecker GF
    Med Chem; 2005 Sep; 1(5):431-44. PubMed ID: 16787327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
    Shagufta ; Kumar A; Panda G; Siddiqi MI
    J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
    Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
    J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
    Babu S; Sohn H; Madhavan T
    Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
    Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.
    Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
    Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
    J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.
    Teixeira C; Gomes JR; Couesnon T; Gomes P
    J Comput Aided Mol Des; 2011 Aug; 25(8):763-75. PubMed ID: 21786172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
    Kaur K; Talele TT
    J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational studies of TGF-βRI (ALK-5) inhibitors: analysis of the binding interactions between ligand-receptor using 2D and 3D techniques.
    Araujo SC; Maltarollo VG; Honorio KM
    Eur J Pharm Sci; 2013 Jul; 49(4):542-9. PubMed ID: 23727056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
    Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
    Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
    Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
    J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.